BIOMAT Database Logo BIOMAT Database Logo

[Group B streptococci: serotyping data and susceptibility to antibiotics (author's transl)]. 1977

A Rousset, and A Lévy, and R Minck

A study of the prevalence of group B streptococci in women (covering 6,000 samples) shows the vaginal presence to be comprised between 6.34 and 16.8%. The highest rate is found in a Centre for venereal diseases. The use of selective media results in a 50 to 75% increase in the number of germ-carries. The distribution found after serotyping of 1,469 strains has been studied. Over half of the strains isolated from the vagina and from infants belong to serotype II and III, one third of the strains causing serious infections are of type III; however, there is a wide dispersion of the serotypes found in neonatal infections. The test for pigmentation on Columbia medium offers an excellent approach for the diagnosis of group B streptococci. MIC testing of 7 antibiotics for 782 strains of various serotypes demonstrates high susceptibility to the beta-lactam antibiotics and makes it possible to detect rare strains with features of polyresistance to chloramphenicol and some macrolide antibiotics.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009305 Nasopharynx The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function. Rhinopharynx,Choanae,Nasopharynges,Nasopharynxes,Rhinopharynges,Rhinopharynxes
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

A Rousset, and A Lévy, and R Minck
[Biochemical types of group-B streptococci (author's transl)].
September 1976, Nordisk veterinaermedicin,
A Rousset, and A Lévy, and R Minck
[Rapidly fatal myocarditis due to group B streptococci (author's transl)].
March 1977, Deutsche medizinische Wochenschrift (1946),
A Rousset, and A Lévy, and R Minck
Serotyping and bacteriophage typing of group B streptococci.
December 1983, NIPH annals,
A Rousset, and A Lévy, and R Minck
[Group D streptococci in human infections: identification and sensitivity to antibiotics (author's transl)].
January 1980, Annales de microbiologie,
A Rousset, and A Lévy, and R Minck
Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid.
January 1985, Scandinavian journal of infectious diseases,
A Rousset, and A Lévy, and R Minck
Novel coagglutination method for serotyping group B streptococci.
December 1992, Journal of clinical microbiology,
A Rousset, and A Lévy, and R Minck
[Group B-streptococci in the female genitals (author's transl)].
January 1975, Archiv fur Gynakologie,
A Rousset, and A Lévy, and R Minck
[Sensitivity of group B Streptococcus to various antibiotics (author's transl)].
February 1981, The Japanese journal of antibiotics,
A Rousset, and A Lévy, and R Minck
[Susceptibility of beta-hemolyzing streptococci of the serological groups A, B, C, F, and G to different antibiotics (author's transl)].
June 1977, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
A Rousset, and A Lévy, and R Minck
Serotyping and bacteriophage typing of human and bovine group-B streptococci.
November 1981, Journal of medical microbiology,
Copied contents to your clipboard!